Clearside Biomedical Inc (CLSD) — Cash Flow Quality Index

Latest as of December 2021: 0.27x

Clearside Biomedical Inc (CLSD) has a Cash Flow Quality Index of 0.27x as of December 2021. Operating cash flow of $5.05 Million is below net income of $18.71 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore total assets of Clearside Biomedical Inc for the complete picture of this company's asset base.

Cash Flow Quality Index

0.27x
Operating CF / Net Income

Operating Cash Flow

$5.05 Million
USD

Net Income

$18.71 Million
USD

Data as of

Dec 2021
Most recent filing

Clearside Biomedical Inc Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Clearside Biomedical Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Clearside Biomedical Inc to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Clearside Biomedical Inc (2021–2021)

Year-by-year earnings quality comparison for Clearside Biomedical Inc. For live market cap and the full company financial profile, see Clearside Biomedical Inc market capitalisation.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -28.55x $-10.73 Million $376.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.